Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.
Clinical trial NCT04063683 · UNKNOWN
Trial details
- NCT number
- NCT04063683
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-07
- Primary completion
- 2022-03-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.